Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea

Sleep

Volumn 31, Issue 12, 2008, Pages 1721-1727

  Lam, Jamie C M ^a   Xu, Aimin ^a,b   Tam, Sidney ^a   Khong, Pek Lan ^a   Yao, Tzy Jyun ^b   Lam, David C L ^a   Lai, Agnes Y K ^a   Lam, Bing ^a   Lam, Karen S L ^a,b   Ip, Mary S M ^a,b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adiponectin; Obstructive sleep apnea; Sympathetic activity

Indexed keywords

ADIPONECTIN; NORADRENALIN; NORMETADRENALIN;

ADULT; AROUSAL; ARTICLE; BODY MASS; CATECHOLAMINE URINE LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HYPOADIPONECTINEMIA; HYPOPROTEINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NORADRENALIN URINE LEVEL; OBESITY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; SYMPATHETIC TONE;

EID: 57349137161     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/31.12.1721     Document Type: Article

References (43)

1. McNicholas WT, Bonsignore MR and the Management Committee of EU COS ACTION b26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Review. Eur Respir J 2007;29:156-178.
2. Gami AS, Somers VK. Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur Heart J 2004;25:709-711.
3. Tasali E, Ip MSM. Obstructive sleep apnea and metabolic syndrome: alterations of glucose metabolism and inflammation. Pro Am Thorac Soc 2008;5:207-217.
4. Ip M, Mokhlesi B. Sleep and glucose intolerance /diabetes mellitus. Sleep Med Clin 2007;2:19-29.
5. Tsao TS, Lodish HF, Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacology 2002;440:213-221.
6. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 1996;120:803-812.
7. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin-a key adipokine in the metabolic syndrome. Diabet Obes Metab 2006;8:264-280.
8. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004;89:2563-2568.
9. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33.
10. Yamauchi T, Kamon, J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946.
11. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001;7: 947-953.
12. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002;50:1884-1888.
13. Mohlig M, Wegewitz U, Osterhoff M, et al. Insulin decreases human adiponectin plasma levels. Horm Metab Res 2002; 34:655-658.
14. Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with corary artery disease in men. Arterio Throm Vasc Bio 2003;23:85-89.
15. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with endstage renal disease. J Am Soc Nephrol 2002;13:134-141.
16. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in man. JAMA 2004;291:1730-1737.
17. Rechtschaffen A, Kales AA, eds. A manual of standardized terminology, techniques and scoring for sleep stages of human subjects. Washington, DC: Government Printing Office. NIH Publication No. 204;1968.
18. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;21:667-689.
19. Meoli AL, Casey KR, Clark RW, et al. Clinical Practice Review Committee. Hypopnea in sleep-disordered breathing in adults. Sleep 2001;24:469-70.
20. Wang Y, Lam KS, Xu JY, et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 2005;280:18341-47.
21. Tso AW, Sham PC, Wat NM, et al. Polymorphisms of the gene encoding adiponectin and glycemic outcome of Chinese subjects with impaired glucose tolerance: a 5-year follow-up study. Diabetologia 2006;49:1806-15.
22. Chow WS, Cheung BM, Tso AW, et al. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 2007;49:1455-67.
23. Chan YP, Siu TS. Simultaneous quantitation of catecholamines and O-methylated metabolites in urine by isocratic ion-pairing high-performance liquid chromatography with amperometric detection. J Chromatogr 1988;459:251-260.
24. Pastoris A, Cerutti L, Sacco R, L De Vecchi, Sbaffi A. Automated analysis of urinary catecholamines by high-performance liquid chromatography and on-line sample pretreatment. J Chromatogr Biomed Appl 1995;664:287-293.
25. Makino S, Handa H, Suzukawa K, et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol 2006;64:12-19.
26. Sharma SK, Kumpawat S, Gael A, Banga A, Ramakrishnam L, Chatnrvedi P. Obesity, not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep disordered breathing. SleepMed 2007;8:12-17.
27. Tauman R, Serpero LD, Capdevila OS, et al. Adipokines in children with sleep disordered breathing. Sleep 2007;30:443-9.
28. Wolk R, Svatikova A, Nelson CA, et al. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obesity Res 2005;13:186-90.
29. McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea. A matched controlled study. Am J Respir Crit Care Med 2007;175:190-195.
30. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. The effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnea and type 2 diabetes. Thorax 2007;62:969-74.
31. Masserini B, Morpurgo PS, Donadio F, et al. Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 2006;29:700-5.
32. Takahashi K, Chin K, Nakamura, et al. Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure. Antioxid Redox Signal 2008;10:715-726.
33. Nakagawa Y, Kishida K, Kihara S, et al. Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea hypopnea syndrome. Am J Physiol Endocrinol Metab 2008;294:E778-84
34. Narkiewicz K, Somers VK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 2003;177:385-90.
35. Ekstedt M, Akerstedt T, Soderstrom M. Microarousals during sleep are associated with increased levels of lipids, cortisol, and blood pressure. Psychosom Med 2004;66:925-931.
36. Spiegel K, Knutson K, LeproultR, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type II diabetes. J Appl Physiol 2005;99:2008-.
37. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 2001;507:142-146.
38. Chernogubova E, Cannon B, Bengtsson T. Norepinephrine increases glucose transport in brown adipocytes via beta3-adrenoceptors through a cAMP, PKA and PI3-kinase-dependent pathway stimulating conventional and novel PKCs. Endocrinology 2004;145:269-280.
39. Xu A, Wong LC, Wang Y, Xu JY, Cooper GLS, Lam KSL. Chronic treatment of growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes. FEBS Lett 2004;572:129-134.
40. Tanida M, Shen J, Horii Y, et al. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp Biol Med (Maywood) 2007;232:390-7.
41. Chen B, Lam KS, Wang Y, et al. Hypoxia desregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun 2006;341:549-56.
42. Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007;293:E1118-28.
43. Yu Wang, Lam KSL, Yau MH, Xu A. Post-translational modifications of adiponectin:mechanisms and functional implications. Review article. Biochem J 2008;409:623-633.